NCT06250556

Brief Summary

Creatine is an effective, inexpensive, and safe dietary supplement, which has been largely used in sports and clinical populations. However, creatine is much less studied in female athletes, with long-term data being particularly scant. This study aims to expand our knowledge on the effects of creatine supplementation in young (Under-20) and elite female football players. This study will comprise two experiments. The first one will be a randomized, controlled trial in which young athletes will be assigned into either creatine or placebo (n = 20). Before and 7 days after supplementation or placebo (4 x 5 g/d of Creapure or dextrose at same dose), athletes will perform a battery of performance tests. Blood and urinary biochemical parameters for assessing the safety of supplementation will be analyzed (creatinine, albuminuria, urea, sodium, potassium, liver enzymes, creatine kinase, hematology). Food intake will be assessed by means of 3-d 24-h dietary recalls. The second experiment will have a quasi-experimental design (i.e., pre-to-post), in which both young and elite football players (n = 70) will be supplemented with creatine (4 x 5 g/d for 7 days and then 5 days during the follow-up) and will be assessed for safety using the above-mentioned markers during the regular football season (\~12 months). Assessments will be carried out at baseline, in the mid-season and after the season.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 9, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

February 10, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

February 9, 2024

Status Verified

January 1, 2024

Enrollment Period

11 months

First QC Date

January 23, 2024

Last Update Submit

January 31, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • kidney function

    serum creatinine levels

    baseline and after the sport season (~12 months)

Secondary Outcomes (9)

  • kidney function

    baseline and after the sport season (~12 months)

  • kidney function

    baseline and after the sport season (~12 months)

  • kidney function

    baseline and after the sport season (~12 months)

  • kidney function

    baseline and after the sport season (~12 months)

  • muscle damage

    baseline and after the sport season (~12 months)

  • +4 more secondary outcomes

Study Arms (1)

creatine supplementation

EXPERIMENTAL
Dietary Supplement: creatine

Interventions

creatineDIETARY_SUPPLEMENT

creatine supplementation (Creapure)

creatine supplementation

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female football players

You may not qualify if:

  • age under 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

School of Medicine of the University of Sao Paulo

São Paulo, Sao Paulo / SP, Brazil

RECRUITING

School of Medicine, University of Sao Paulo

São Paulo, 05403-000, Brazil

RECRUITING

MeSH Terms

Interventions

Creatine

Intervention Hierarchy (Ancestors)

GuanidinesAmidinesOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and Proteins

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: pre-to-post design for experiment 2.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 23, 2024

First Posted

February 9, 2024

Study Start

February 10, 2024

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

February 9, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

Data will be made available upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE

Locations